MAP1LC3A and hepatocellular carcinoma: Similarly, IHC was performed on HCC samples from 80 clinical patients, resulting in a malignant degree of hepatocellular carcinoma, lower CYB5A and LC3 expression levels, and higher STOML2 and p-STAT3 expression levels (Fig. 6A, B).